Susumu Tonegawa, Nobel Laureate and Visionary Immunologist, Passes Away at 86
admin The global scientific community is profoundly saddened by the passing of Dr. Susumu Tonegawa, a...
biotech
Biohaven Divests Flagship Epilepsy Drug Opakalim to SK Biopharmaceuticals Amidst Financial Strain and Pipeline Restructuring
Biohaven Pharmaceuticals, a company in its second iteration following a high-profile acquisition and subsequent spin-off,...
Cancer Research Institute Launches Landmark IGNITE Award to Bridge Critical Funding Gap for Next-Generation Immunotherapy Scientists
In a pivotal move to safeguard the future of cancer research, the Cancer Research Institute...
Spyre tumbles as immune drug misses mark in rheumatoid arthritis
The biopharmaceutical landscape witnessed a significant tremor on Wednesday, August 26, 2026, as Spyre Therapeutics,...
Safeguarding Your Skin: July Marks Ultraviolet Radiation Safety Awareness Month Amidst Immunotherapy Breakthroughs
July serves as a critical period for public health, designated as Ultraviolet (UV) Radiation Safety...
Rasonque Secures Rapid FDA Approval, Heralding a New Era for Pancreatic Cancer Treatment and Positioning Revolution Medicines for Blockbuster Success.
The biopharmaceutical landscape was fundamentally reshaped on August 26, 2026, with the unprecedentedly swift approval...
Cellares Initiates Major Restructuring and Layoffs Following Termination of Key Pharmaceutical Contract
Cellares, a prominent biotechnology startup specializing in automated cell therapy manufacturing, is undergoing a significant...
New Jazz cancer drug approval could drive blockbuster sales
The U.S. Food and Drug Administration (FDA) has granted an expanded approval for Ziihera (zanidatamab)...
Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test
The landscape of Alzheimer’s disease diagnostics is poised for a significant transformation with the announcement...
Venture Capital Funding for Women’s Health Plummets Amid Broader Market Reset, Sparks Strategic Re-evaluation
After experiencing a surge to record levels in 2024, venture capital investments in women’s health...
